Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pre-Eclampsia 1 Lymphoma, Follicular 1

Interventions

Cyclophosphamide 27 Vincristine 24 Dexamethasone 22 Rituximab 21 Methotrexate 21 Cytarabine 21 Mercaptopurine 16 Doxorubicin 15 Etoposide 13 Asparaginase 13 Daunorubicin 12 Prednisone 10 Prednisolone 10 Granulocyte Colony-Stimulating Factor 10 Ifosfamide 8 Idarubicin 8 fludarabine 7 pegylated granulocyte colony-stimulating factor 6 Thioguanine 6 Teniposide 6 Vindesine 5 Brentuximab Vedotin 5 ibrutinib 4 fludarabine phosphate 4 Stem Cell Transplantation 4 Gemcitabine 4 Cisplatin 4 Aprepitant 4 zanubrutinib 3 prednylidene 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Furosemide × Lymphoid × Clear all

NCT07167862 2026-01-23

PPPOCUS

University of California, Irvine

Phase 4 Not yet recruiting

Lymphoma, Follicular, Pre-Eclampsia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡